Table 3.
Patient characteristics | Unadjusted OR (95% CI) | p-value* | Adjusted OR‡ (95% CI) | p-value* |
---|---|---|---|---|
Age (years) | 1.02 (0.99–1.06) | 0.219 | 0.96 (0.92–1.01) | 0.086 |
Male gender | 1.10 (0.62–1.97) | 0.742 | 1.17 (0.60–2.28) | 0.64 |
History of substance use | 1.09 (0.59–2.01) | 0.783 | ||
History of psychiatric comorbidity | 0.88 (0.51–1.54) | 0.661 | ||
HIV coinfection | 0.63 (0.21–1.87) | 0.402 | ||
HBV coinfection | 0.50 (0.03–8.16) | 0.629 | ||
Cirrhosis | 1.06 (0.41–2.72) | 0.91 | ||
Decompensated liver disease | 2.80 (0.79–9.93) | 0.111 | ||
≥ 2 Medical comorbidities† | 3.11 (1.04–9.35) | 0.043 | 1.42 (0.44–4.57) | 0.552 |
Direct acting antiviral agent availability | 7.62 (4.12–14.1) | < 0.001 | 10.3 (4.84–22.0) | < 0.001 |
p-value < 0.05 considered statistically significant and bolded.
Adjusted for age, gender, and insurance status. OR: odds ratio.
Defined as presence of diabetes, heart disease, or chronic kidney disease (eGFR < 60).